ES2032277T3 - Procedimiento para el pasteurizado de plasmaproteinas y de fracciones de plasmaproteinas. - Google Patents

Procedimiento para el pasteurizado de plasmaproteinas y de fracciones de plasmaproteinas.

Info

Publication number
ES2032277T3
ES2032277T3 ES198787103313T ES87103313T ES2032277T3 ES 2032277 T3 ES2032277 T3 ES 2032277T3 ES 198787103313 T ES198787103313 T ES 198787103313T ES 87103313 T ES87103313 T ES 87103313T ES 2032277 T3 ES2032277 T3 ES 2032277T3
Authority
ES
Spain
Prior art keywords
pasteurizing
fractions
plasmaproteinas
plasmaprotein
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787103313T
Other languages
English (en)
Spanish (es)
Inventor
Walter Prof.Dr. Doleschel
Walter Norbert Dr. Doleschel
Helmut Dr. Kaltschmid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heilmittelwerke Wien GmbH
Original Assignee
Heilmittelwerke Wien GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heilmittelwerke Wien GmbH filed Critical Heilmittelwerke Wien GmbH
Application granted granted Critical
Publication of ES2032277T3 publication Critical patent/ES2032277T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES198787103313T 1986-03-18 1987-03-09 Procedimiento para el pasteurizado de plasmaproteinas y de fracciones de plasmaproteinas. Expired - Lifetime ES2032277T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0071986A AT390374B (de) 1986-03-18 1986-03-18 Verfahren zum pasteurisieren von plasmaprotein und plasmaproteinfraktionen

Publications (1)

Publication Number Publication Date
ES2032277T3 true ES2032277T3 (es) 1993-02-01

Family

ID=3498006

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787103313T Expired - Lifetime ES2032277T3 (es) 1986-03-18 1987-03-09 Procedimiento para el pasteurizado de plasmaproteinas y de fracciones de plasmaproteinas.

Country Status (6)

Country Link
US (1) US4803073A (2)
EP (1) EP0240750B1 (2)
AT (2) AT390374B (2)
DE (1) DE3778956D1 (2)
ES (1) ES2032277T3 (2)
GR (1) GR3004593T3 (2)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
AU5082698A (en) * 1996-10-23 1998-05-15 Oravax, Inc Heat inactivation of viruses in antibody preparations
EP2921180B1 (en) 1999-02-22 2019-08-14 University of Connecticut Albumin-free factor VIII formulations
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
ZA838856B (en) * 1982-12-02 1984-07-25 Usv Pharma Corp Hepatitis b and non-a-non-b-safe biological products
CA1208551A (en) * 1982-12-27 1986-07-29 Ricardo H. Landaburu Solvent treatment of plasma protein products
US4490361A (en) * 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives

Also Published As

Publication number Publication date
US4803073A (en) 1989-02-07
AT390374B (de) 1990-04-25
EP0240750A3 (en) 1989-07-26
ATE75951T1 (de) 1992-05-15
GR3004593T3 (2) 1993-04-28
ATA71986A (de) 1989-10-15
EP0240750A2 (de) 1987-10-14
DE3778956D1 (de) 1992-06-17
EP0240750B1 (de) 1992-05-13

Similar Documents

Publication Publication Date Title
US4632980B1 (2)
ES551761A0 (es) Un procedimiento para la preparacion de un vector de dna recombinante
ES8703490A1 (es) Un procedimiento para producir un polipeptido que tiene o contiene un polipeptido de factor de necrosis de tumor humano
ES2181725T3 (es) Inhibidores de hiv proteasa.
ES2094111T3 (es) Proteinas con actividad de factor viii, procedimiento para su produccion que utilizan celulas modificadas por ingenieria genetica y composiciones farmaceuticas que las contienen.
NO872988D0 (no) Pattedyr-interleukin-4.
ES2056843T3 (es) Amidas de acidos grasos inhibidoras de acil-coa: colesterol aciltransferasa.
ES2058244T3 (es) Procedimiento para produccion de avermectinas y cultivos para el mismo.
ES2033981T3 (es) Procedimiento para la preparacion de proteinas bifuncionales.
ES2055686T3 (es) Procedimiento para preparar proteinas con factor de granulocitos-macrofagos "estimulador de colonias".
ES2118058T3 (es) Factor de crecimiento de las celulas t.
ES2032277T3 (es) Procedimiento para el pasteurizado de plasmaproteinas y de fracciones de plasmaproteinas.
ES2058272T3 (es) Fluoxetina util para el tratamiento de la diabetes.
PT951553E (pt) Proteinas de e4 de adenovirus para unducao de morte celular
EP0206200A3 (en) Human cholinesterase-type proteins and their production
ATE69816T1 (de) 12- und 13-brom-ergolinderivate.
ES2169040T3 (es) Planta resistente a dos o mas virus y preparacion de la misma.
ES2077707T3 (es) Procedimiento para la inactivacion de la actividad biologica de adn.
AR240063A1 (es) Procedimiento para la produccion del activador del plasminogeno del tejido humano mediante el cultivo de la cepa de celulas registrada como kym-sf ifo 50135.
DE3583467D1 (de) Nervenregenerierung.
IT8619306A1 (it) Procedimento e composizione per combattere la tignola crociata della vite
ES2059826T3 (es) Utilizacion de quimotripsina para inactivar el activador de precalicreina en productos sanguineos derivados de plasma humano o animal.
DE3878000D1 (de) Verschmolzenes biologisches bekaempfungsmittel.
ES296446Y (es) Disposicion de union entre las secciones de electrodos de carbon o de grafito
GT197853919A (es) Procedimiento para la obtencion de un derivado estable y de accion terapeutica de la d(-) alfa aminobencilpenicilina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 240750

Country of ref document: ES